Product Program year 2025 Source: CMS Open Payments

Orise

Device Orise_Endo

PDI 08714729974604

Open in the dashboard

General payments

$586,847

2,198 payments

Research payments

$0

0 payments

Through program year 2025, $586,847 in general payments and $0 in research payments were reported against Orise (Orise_Endo).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $190,418 434
2024 General $110,609 491
2023 General $108,510 449
2022 General $177,310 824

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $586,847 2,198 payments
Top recipients General payments · program year 2025
  1. Joo Hwang Gastroenterology · Stanford, CA $32,444 17% · 36 payments
  2. Hiroyuki Aihara Gastroenterology · Boston, MA $24,531 13% · 22 payments
  3. Norio Fukami Gastroenterology · Scottsdale, AZ $18,109 10% · 23 payments
  4. Amrita Sethi Gastroenterology · New York, NY $16,250 9% · 9 payments
  5. Peter Draganov Gastroenterology · Gainesville, FL $15,460 8% · 16 payments

The top 5 of 94 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $186,513 98% · 65 practitioners
  2. Internal Medicine $1,776 <1% · 8 practitioners
  3. Surgery $945 <1% · 1 practitioner
  4. Colon & Rectal Surgery $734 <1% · 2 practitioners
  5. Emergency Medicine $71 <1% · 1 practitioner

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $46,589 24% · 12 recipients
  2. Texas $27,013 14% · 31 recipients
  3. Massachusetts $24,531 13% · 1 recipient
  4. Arizona $18,109 10% · 1 recipient
  5. New York $16,252 9% · 2 recipients

The top 5 of 31 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,198 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record